MREO
Mereo BioPharma
MREO
MREO
64 hedge funds and large institutions have $71.8M invested in Mereo BioPharma in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
28% less capital invested
Capital invested by funds: $99.6M → $71.8M (-$27.8M)
Holders
64
Holding in Top 10
–
Calls
$336K
Puts
$221K
Top Buyers
| 1 | +$2.52M | |
| 2 | +$1.97M | |
| 3 | +$1.97M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$1.12M |
| 5 |
E
Ergoteles
New York
|
+$593K |
Top Sellers
| 1 | -$4.25M | |
| 2 | -$3.33M | |
| 3 | -$2.84M | |
| 4 |
CC
Commodore Capital
New York
|
-$2.19M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.63M |